Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Int J Pharm ; 572: 118783, 2019 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-31678393

RESUMO

The purpose of this study was to develop a novel gastroretentive drug delivery system with immediate buoyancy and high wet strength. The proposed bilayer tablet was composed of a drug layer and a highly porous and swellable gastroretentive (GR) layer. The highly porous GR layer was prepared by sublimating the volatile materials after compaction with swellable polymers. This pore-forming process decreased the density of the GR layer and enabled the tablet to float immediately on the dissolution media. The GR layer formulation was optimized by comparing the swelling, erosion, and mechanical properties of candidate swellable polymers. The release rates were conveniently controlled by changing the polymer content in the drug layer, while the swelling and floating properties were provided by the GR layer. The application of percolation theory revealed that the polymer content above the estimated threshold was required for a reliable drug release profile. In vivo study in fed beagle dogs confirmed the enhanced gastric retention time of the tablets compared to that of conventional single layer tablets. Taken together, our data suggest that the proposed system can be a promising platform technology with superior GR properties and a convenient formulation process.


Assuntos
Portadores de Fármacos , Antagonistas dos Receptores H2 da Histamina/administração & dosagem , Polímeros/química , Ranitidina/administração & dosagem , Administração Oral , Animais , Cães , Composição de Medicamentos , Liberação Controlada de Fármacos , Absorção Gástrica , Esvaziamento Gástrico , Antagonistas dos Receptores H2 da Histamina/química , Antagonistas dos Receptores H2 da Histamina/farmacocinética , Masculino , Porosidade , Período Pós-Prandial , Ranitidina/química , Ranitidina/farmacocinética , Solubilidade , Comprimidos
2.
Pharm Dev Technol ; 23(9): 890-899, 2018 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-28535125

RESUMO

The objectives of this study were to prepare cocrystal composed of adefovir dipivoxil (AD) and stearic acid (SA) and to investigate the enhanced properties of the cocrystal. The cocrystal was prepared by antisolvent precipitation and characterized by scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FT-IR), X-ray powder diffraction (XRPD), and differential scanning calorimetry (DSC). The enhanced properties were evaluated by dissolution testing, permeability studies, and powder rheology analysis. The AD raw material has a cuboid-like crystal and the cocrystal has a needle shape. In the FT-IR study, there were bathochromic shifts caused by the hydrogen bonding. The melting point of the cocrystal was 52.9 °C, which was lower than that of AD. The XRPD pattern also had distinct differences, supporting the formation of a new crystalline form. The cocrystal showed changes in the lattice energy and the solvation strength, which caused an enhanced dissolution. The permeability was increased due to the SA, which acts as a P-gp inhibitor. The tabletability was enhanced due to the altered crystal habit. In conclusion, cocrystal containing AD and SA was successfully prepared, presenting advantages such as enhanced solubility, tabletability, and permeability. The use of the cocrystal is a desirable approach for the improved physicochemical properties.


Assuntos
Adenina/análogos & derivados , Fenômenos Químicos , Química Farmacêutica/métodos , Organofosfonatos/síntese química , Ácidos Esteáricos/síntese química , Adenina/análise , Adenina/síntese química , Adenina/farmacocinética , Microscopia Eletrônica de Varredura/métodos , Organofosfonatos/análise , Organofosfonatos/farmacocinética , Espectroscopia de Infravermelho com Transformada de Fourier/métodos , Ácidos Esteáricos/análise , Ácidos Esteáricos/farmacocinética , Difração de Raios X/métodos
3.
Int J Pharm ; 529(1-2): 410-422, 2017 Aug 30.
Artigo em Inglês | MEDLINE | ID: mdl-28705620

RESUMO

This study focuses on evaluating the potential of transferring from a batch process to continuous process for manufacturing of the extended release formulation. Metformin hydrochloride (HCl) was used in the model formulation which was intended to contain the high amount of hydrophilic drug. The effects of barrel temperature, binder type, powder feed rate, and screw speed on granule properties (size and strength) and torque value in twin screw granulation were investigated. Due to the high content of hydrophilic model drug, the granules prepared at a higher temperature with HPMC binding solution had the narrower size distribution and greater strength than the granules prepared with distilled water as a binding solution. After continuous drying and milling steps, the granules (continuous process) satisfied the fundamental purpose of granulation with size and flowability, despite different shape compared with the granules (batch process). Furthermore, there were no significant differences between two granulation processes in tablet properties, such as tablet hardness and in vitro release. The considerations and strategies used in this study to transfer from a batch to continuous process can be applied to other existing formulations based on high shear granulation to enable rapid process transfer in the pharmaceutical industry.


Assuntos
Composição de Medicamentos , Metformina/administração & dosagem , Química Farmacêutica , Preparações de Ação Retardada/química , Tamanho da Partícula , Comprimidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA